EFFERALGAN Side Effects

6451414-X | Cytolytic Hepatitis, Prothrombin Level Decreased
on Nov 18, 2009 Female patient from FRANCE , 70 years of age, was diagnosed with tooth disorder (What is tooth disorder?) and was treated with Efferalgan (View Usage). Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis, prothrombin level decreased. Efferalgan dosage: . During the same period patient was treated with APROVEL (View Aprovel Review and Aprovel Label ), TAHOR (View Tahor Review and Tahor Label ), INIPOMP (View Inipomp Review and Inipomp Label ), BIRODOGYL (View Birodogyl Review and Birodogyl Label ), INSULIN (View Insulin Review and Insulin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6348770-X | Cytolytic Hepatitis, Prothrombin Level Decreased
Patient was taking Efferalgan (View Usage). Patient had the following side effects: cytolytic hepatitis, prothrombin level decreased on Sep 07, 2009 from FRANCE Additional patient health information: Female patient , 70 years of age, was diagnosed with tooth disorder (What is tooth disorder?) and. Efferalgan dosage: . During the same period patient was treated with APROVEL (View Aprovel Review and Aprovel Label ), TAHOR (View Tahor Review and Tahor Label ), INIPOMP (View Inipomp Review and Inipomp Label ), BIRODOGYL (View Birodogyl Review and Birodogyl Label ), INSULIN (View Insulin Review and Insulin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

5166649-6 | Dyspnoea, Fatigue, Increased Bronchial Secretion, Inflammation, Pseudomonas Infection, Pyrexia, Staphylococcal Infection
Adverse event was reported on Aug 02, 2006 by a Male patient taking Efferalgan (View Usage) (Dosage: ) was diagnosed with pseudomonas infection, chest pain (What is chest pain?) and. Location: FRANCE , 30 years of age, After Efferalgan was administered, patient had the following side effects: dyspnoea, fatigue, increased bronchial secretion, inflammation, pseudomonas infection, pyrexia, staphylococcal infection (What is staphylococcal infection?). During the same period patient was treated with DAFALGAN (View Dafalgan Review and Dafalgan Label ), COLCHICINE (View Colchicine Review and Colchicine Label ), TOBI; CHIRON CORPORATION (300 Mg, Bid) (View Tobi; Chiron Corporation Review and Tobi; Chiron Corporation Label ), MYOLASTAN (200 Mg, Once) (View Myolastan Review and Myolastan Label ). Patient was hospitalized.

5157076-6 | Abdominal Pain, Alanine Aminotransferase, Aspartate Aminotransferase Increased, Asthenia, Atrial Fibrillation, Cardiac Failure, Cardiogenic Shock, Cardiomyopathy, Dizziness
on Jun 08, 2006 Male patient from FRANCE , 21 years of age, weighting 92.59 lb, was diagnosed with headache (What is headache?), blood iron increased and was treated with Efferalgan (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), alanine aminotransferase, aspartate aminotransferase increased, asthenia, atrial fibrillation (What is atrial fibrillation?), cardiac failure, cardiogenic shock, cardiomyopathy (What is cardiomyopathy?), dizziness (What is dizziness?). Efferalgan dosage: . During the same period patient was treated with EXJADE (875 Mg, Qd) (View Exjade Review and Exjade Label ). Patient was hospitalized.


5145963-4 | Abdominal Pain, Alanine Aminotransferase, Aspartate Aminotransferase Increased, Asthenia, Atrial Fibrillation, Cardiogenic Shock, Cardiomyopathy, Dizziness, Dyspnoea
on Jun 08, 2006 Male patient from FRANCE , 21 years of age, weighting 92.59 lb, was diagnosed with headache (What is headache?), blood iron increased and was treated with Efferalgan (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), alanine aminotransferase, aspartate aminotransferase increased, asthenia, atrial fibrillation (What is atrial fibrillation?), cardiogenic shock, cardiomyopathy (What is cardiomyopathy?), dizziness (What is dizziness?), dyspnoea. Efferalgan dosage: . During the same period patient was treated with EXJADE (875 Mg, Qd) (View Exjade Review and Exjade Label ). Patient was hospitalized.

5058440-6 | Abdominal Pain, Alanine Aminotransferase, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Asthenia, Cardiomyopathy, Dizziness, Dyspnoea, Face Oedema
Patient was taking Efferalgan (View Usage). After Efferalgan was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), alanine aminotransferase, alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, cardiomyopathy (What is cardiomyopathy?), dizziness (What is dizziness?), dyspnoea, face oedema on Jun 08, 2006 from FRANCE Additional patient health information: Male patient , 21 years of age, weighting 92.59 lb, was diagnosed with headache (What is headache?), blood iron increased and. Efferalgan dosage: . During the same period patient was treated with ICL670A (875 Mg, Qd) (View Icl670a Review and Icl670a Label ). Patient was hospitalized.

5043616-4 | Anaemia, Asthenia, Bone Marrow Myelogram Abnormal, Myeloid Leukaemia, Thrombocytopenia
Adverse event was reported on Apr 25, 2006 by a Female patient taking Efferalgan (View Usage) (Dosage: Unk, Prn) was diagnosed with hypothyroidism, gastritis, hypertension and. Location: FRANCE , 65 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, asthenia, bone marrow myelogram abnormal, myeloid leukaemia, thrombocytopenia. During the same period patient was treated with LEVOTHYROX (100 Ug, Qd) (View Levothyrox Review and Levothyrox Label ), OGAST (15 Mg, Qd) (View Ogast Review and Ogast Label ), COTAREG (1 Df, Qd) (View Cotareg Review and Cotareg Label ). Patient was hospitalized.

5040746-8 | Abdominal Pain, Alanine Aminotransferase, Aspartate Aminotransferase Increased, Asthenia, Cardiomyopathy, Dizziness, Dyspnoea, Face Oedema, Haemoglobin Decreased
on Jun 08, 2006 Male patient from FRANCE , 21 years of age, weighting 92.59 lb, was diagnosed with headache (What is headache?), blood iron increased and was treated with Efferalgan (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), alanine aminotransferase, aspartate aminotransferase increased, asthenia, cardiomyopathy (What is cardiomyopathy?), dizziness (What is dizziness?), dyspnoea, face oedema, haemoglobin decreased. Efferalgan dosage: . During the same period patient was treated with ICL670A (875 Mg, Qd) (View Icl670a Review and Icl670a Label ). Patient was hospitalized.

5028638-1 | Abdominal Pain, Alanine Aminotransferase, Aspartate Aminotransferase Increased, Asthenia, Dizziness, Face Oedema, Haemoglobin Decreased, Headache, Nausea
on Jun 08, 2006 Male patient from FRANCE , 21 years of age, weighting 92.59 lb, was diagnosed with headache (What is headache?), blood iron increased and was treated with Efferalgan (View Usage). After Efferalgan was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), alanine aminotransferase, aspartate aminotransferase increased, asthenia, dizziness (What is dizziness?), face oedema, haemoglobin decreased, headache (What is headache?), nausea (What is nausea?). Efferalgan dosage: . During the same period patient was treated with ICL670A (875 Mg, Qd) (View Icl670a Review and Icl670a Label ). Patient was hospitalized.

5028403-5 | Abdominal Pain, Alanine Aminotransferase, Aspartate Aminotransferase Increased, Asthenia, Dizziness, Face Oedema, Haemoglobin Decreased, Headache, Nausea
Patient was taking Efferalgan (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), alanine aminotransferase, aspartate aminotransferase increased, asthenia, dizziness (What is dizziness?), face oedema, haemoglobin decreased, headache (What is headache?), nausea (What is nausea?) on Jun 08, 2006 from FRANCE Additional patient health information: Male patient , 21 years of age, weighting 92.59 lb, was diagnosed with headache (What is headache?), blood iron increased and. Efferalgan dosage: . During the same period patient was treated with ICL670A (875 Mg, Qd) (View Icl670a Review and Icl670a Label ). Patient was hospitalized.

4853672-1 | Agranulocytosis, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased
Adverse event was reported on Dec 06, 2005 by a Male patient taking Efferalgan (View Usage) (Dosage: ) was diagnosed with knee operation and. Location: FRANCE , 45 years of age, Patient had the following side effects: agranulocytosis, alanine aminotransferase increased, aspartate aminotransferase increased. During the same period patient was treated with AMIKIN (View Amikin Review and Amikin Label ), AXEPIM (View Axepim Review and Axepim Label ), MYOLASTAN (View Myolastan Review and Myolastan Label ), MOPRAL (View Mopral Review and Mopral Label ), BI PROFENID (View Bi-profenid Review and Bi-profenid Label ). Patient was hospitalized.

4748212-1 | Acute Respiratory Distress Syndrome, Bronchopleural Fistula, Condition Aggravated, Sepsis, Septic Shock, White Blood Cell Count Increased
on Aug 08, 2005 Female patient from FRANCE , 74 years of age, was diagnosed with back pain (What is back pain?) and was treated with Efferalgan (View Usage). After Efferalgan was administered, patient had the following side effects: acute respiratory distress syndrome, bronchopleural fistula, condition aggravated, sepsis (What is sepsis?), septic shock, white blood cell count increased. Efferalgan dosage: . During the same period patient was treated with MUCOMYST (View Mucomyst Review and Mucomyst Label ), BROMAZEPAM (View Bromazepam Review and Bromazepam Label ), FELDENE (View Feldene Review and Feldene Label ). Patient was hospitalized.

4596485-0 | Hypokalaemia, Hyponatraemia
on Feb 18, 2005 Female patient from , 75 years of age, was diagnosed with hypertension, dysthymic disorder, back pain (What is back pain?), diabetes mellitus and was treated with Efferalgan (View Usage). Patient experienced the following unwanted or unexpected effects: hypokalaemia, hyponatraemia. Efferalgan dosage: . During the same period patient was treated with PIASCLEDINE (Unk) (View Piascledine Review and Piascledine Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), STILNOX (View Stilnox Review and Stilnox Label ), TANAKAN (View Tanakan Review and Tanakan Label ), SOPROL (Unk) (View Soprol Review and Soprol Label ), PROZAC (View Prozac Review and Prozac Label ), FELDENE (Unk) (View Feldene Review and Feldene Label ), DIAMICRON (Unk) (View Diamicron Review and Diamicron Label ). Patient was hospitalized.